Lauri Lehtimäki

Summary

Affiliation: University of Tampere
Country: Finland

Publications

  1. doi request reprint Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study
    Lauri Lehtimäki
    Immunopharmacology Research Group, Medical School, University of Tampere, Tampere FI 33014, Finland
    Int Arch Allergy Immunol 149:150-3. 2009
  2. doi request reprint Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
    L Lehtimäki
    The Immunopharmacology Research Group, Medical School, University of Tampere, Tampere, Finland
    Eur Respir J 35:72-8. 2010
  3. doi request reprint Pulmonary inflammation in asbestos-exposed subjects with borderline parenchymal changes on HRCT
    Lauri Lehtimäki
    The Immunopharmacology Research Group, Medical School, University of Tampere, Finland
    Respir Med 104:1042-9. 2010
  4. doi request reprint Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents
    Laura Linkosalo
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    Pediatr Allergy Immunol 23:360-6. 2012
  5. doi request reprint Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers
    Riitta Sauni
    Finnish Institute of Occupational Health, Tampere, PO Box 486, FI 33101 Tampere, Finland
    Occup Environ Med 69:256-60. 2012
  6. doi request reprint Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis
    Tarja Makinen
    Department of Respiratory Medicine, Medical School, University of Tampere, Tampere University Hospital, Tampere, Finland
    Int Arch Allergy Immunol 148:154-60. 2009
  7. ncbi request reprint Peripheral inflammation in patients with asthmatic symptoms but normal lung function
    Lauri Lehtimäki
    Immunopharmacological Research Group, Medical School, University of Tampere, Finland
    J Asthma 42:605-9. 2005
  8. doi request reprint Alveolar and bronchial nitric oxide output in healthy children
    Anna Sepponen
    The Immunopharmacology Research Group, Medical School, University of Tampere, Tampere, Finland
    Pediatr Pulmonol 43:1242-8. 2008
  9. pmc Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1
    Riku Korhonen
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    Br J Pharmacol 169:1525-36. 2013
  10. pmc Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma
    Sirpa Leivo-Korpela
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    J Inflamm (Lond) 8:12. 2011

Collaborators

Detail Information

Publications12

  1. doi request reprint Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study
    Lauri Lehtimäki
    Immunopharmacology Research Group, Medical School, University of Tampere, Tampere FI 33014, Finland
    Int Arch Allergy Immunol 149:150-3. 2009
    ..Our aim was to assess if montelukast could be used to treat all the various symptoms seen in subjects with atopic syndrome...
  2. doi request reprint Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
    L Lehtimäki
    The Immunopharmacology Research Group, Medical School, University of Tampere, Tampere, Finland
    Eur Respir J 35:72-8. 2010
    ..Markers of inflammation or oxidative stress in EBC are not related to steroid responsiveness in COPD...
  3. doi request reprint Pulmonary inflammation in asbestos-exposed subjects with borderline parenchymal changes on HRCT
    Lauri Lehtimäki
    The Immunopharmacology Research Group, Medical School, University of Tampere, Finland
    Respir Med 104:1042-9. 2010
    ..Such borderline parenchymal changes are likely a mild or early form of the same pathological process that leads to asbestosis...
  4. doi request reprint Relation of bronchial and alveolar nitric oxide to exercise-induced bronchoconstriction in atopic children and adolescents
    Laura Linkosalo
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    Pediatr Allergy Immunol 23:360-6. 2012
    ..Also, the respective NO parameters corrected for axial backward diffusion (J'aw(NO) [TMAD] and CA(NO) [TMAD]) were calculated and included in the analysis...
  5. doi request reprint Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers
    Riitta Sauni
    Finnish Institute of Occupational Health, Tampere, PO Box 486, FI 33101 Tampere, Finland
    Occup Environ Med 69:256-60. 2012
    ..Inflammatory mediators including cytokines are known to take part in silica-induced processes, but the role of adipokines has not been studied previously...
  6. doi request reprint Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis
    Tarja Makinen
    Department of Respiratory Medicine, Medical School, University of Tampere, Tampere University Hospital, Tampere, Finland
    Int Arch Allergy Immunol 148:154-60. 2009
    ....
  7. ncbi request reprint Peripheral inflammation in patients with asthmatic symptoms but normal lung function
    Lauri Lehtimäki
    Immunopharmacological Research Group, Medical School, University of Tampere, Finland
    J Asthma 42:605-9. 2005
    ..In conclusion, patients with asthmatic symptoms but normal lung function have increased alveolar NO concentration and mildly elevated bronchial NO flux suggesting a more peripheral inflammation than in patients with asthma...
  8. doi request reprint Alveolar and bronchial nitric oxide output in healthy children
    Anna Sepponen
    The Immunopharmacology Research Group, Medical School, University of Tampere, Tampere, Finland
    Pediatr Pulmonol 43:1242-8. 2008
    ..Reference values in healthy children are of value when applying bronchial and alveolar NO parameters in the diagnostics and follow-up of inflammatory lung diseases...
  9. pmc Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1
    Riku Korhonen
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    Br J Pharmacol 169:1525-36. 2013
    ..In the present study, we investigated the effect of a PDE4 inhibitor rolipram on MKP-1 expression and whether MKP-1 is involved in the anti-inflammatory effects of rolipram...
  10. pmc Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma
    Sirpa Leivo-Korpela
    The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland
    J Inflamm (Lond) 8:12. 2011
    ..abstract:..
  11. pmc Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin
    Anna Tahvanainen
    Department of Internal Medicine, University of Tampere, Tampere, Sweden
    Br J Clin Pharmacol 68:23-33. 2009
    ..To examine the effects of salbutamol and L-arginine, two compounds acting largely on the endothelium, and the endothelium-independent agent nitroglycerin on blood pressure, arterial compliance, cardiac function and vascular resistance...
  12. ncbi request reprint Increased bronchial NO output in severe atopic eczema in children and adolescents
    Laura Linkosalo
    The Immunopharmacology Research Group, Medical School, University of Tempere and Research Unit, Tempere University Hospital, Tempere, Finland
    Pediatr Allergy Immunol 19:426-32. 2008
    ..The results show that increased bronchial NO output is associated with eosinophilic inflammation and severe atopic eczema in patients without established asthma...